|
Arterial thrombosis
Citations 201-210 of 336 total displayed.
|
Past content
(since Oct 2000):
|
- Articles
Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation
- Allen Jeremias, Brett Sylvia, Jonathan Bridges, Ajay J. Kirtane, Brian Bigelow, Duane S. Pinto, Kalon K.L. Ho, David J. Cohen, Lawrence A. Garcia, Donald E. Cutlip, and Joseph P. Carrozza, Jr
Circulation published April 12, 2004, doi:10.1161/01.CIR.0000127105.99982.21
[Abstract]
- Articles
Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages. Evidence for Apoptosis as Link Between Inflammation and Atherothrombosis
- Randolph Hutter, Carolina Valdiviezo, Bernhard V. Sauter, Mikko Savontaus, Igor Chereshnev, Francine E. Carrick, Gerhard Bauriedel, Berndt Lüderitz, John T. Fallon, Valentin Fuster, and Juan J. Badimon
Circulation published April 12, 2004, doi:10.1161/01.CIR.0000125526.91945.AE
[Abstract]
- Articles
In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent
- René M. Botnar, Alexandra S. Perez, Sonia Witte, Andrea J. Wiethoff, James Laredo, James Hamilton, William Quist, Edward C. Parsons, Jr, Anand Vaidya, Andrew Kolodziej, John A. Barrett, Philip B. Graham, Robert M. Weisskoff, Warren J. Manning, and Michael T. Johnstone
Circulation published April 5, 2004, doi:10.1161/01.CIR.0000127034.50006.C0
[Abstract]
- Clinical Investigations and Reports
Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial
- Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, Walter Lehmacher, Werner Günther Daniel, Peter Hanrath, Christoph Geller, Andreas Mügge, Walter Sehnert, Caroline Schmidt-Lucke, Jan-André Schmidt-Lucke on Behalf of the ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group
Circulation 2004;109:997-1003; published online before print as doi:10.1161/01.CIR.0000120509.64740.DC
[Abstract]
[Full text]
- Clinical Investigations and Reports
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?
- Renu Virmani, Giulio Guagliumi, Andrew Farb, Giuseppe Musumeci, Niccolo Grieco, Teresio Motta, Laurian Mihalcsik, Maurizio Tespili, Orazio Valsecchi, and Frank D. Kolodgie
Circulation 2004;109:701-705; published online before print as doi:10.1161/01.CIR.0000116202.41966.D4
[Abstract]
[Full text]
- Articles
Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation. The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial
- Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, Walter Lehmacher, Werner Günther Daniel, Peter Hanrath, Christoph Geller, Andreas Mügge, Walter Sehnert, Caroline Schmidt-Lucke, Jan-André Schmidt-Lucke on Behalf of the ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000120509.64740.DC
[Abstract]
- Clinical Investigations and Reports
High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary Intervention
- Nobuyuki Takamori, Hiroyuki Azuma, Midori Kato, Shunji Hashizume, Ken-ichi Aihara, Masashi Akaike, Katsuya Tamura, and Toshio Matsumoto
Circulation 2004;109:481-486; published online before print as doi:10.1161/01.CIR.0000109695.39671.37
[Abstract]
[Full text]
- Articles
High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary Intervention
- Nobuyuki Takamori, Hiroyuki Azuma, Midori Kato, Shunji Hashizume, Ken-ichi Aihara, Masashi Akaike, Katsuya Tamura, and Toshio Matsumoto
Circulation published January 26, 2004, doi:10.1161/01.CIR.0000109695.39671.37
[Abstract]
- Correspondence
A Possible Explanation of Statistical Interaction, With Application to the Effects of Soluble Thrombomodulin and Soluble Intercellular Adhesion Molecule-1 on Coronary Heart Disease • Response
- T. Paul Hutchinson, Kenneth K. Wu, Nena Aleksic, Chul Ahn, Harinder Juneja, Eric Boerwinkle, and Christie M. Ballantyne
Circulation 2003;108:e175, doi:10.1161/01.CIR.0000108175.90859.91
[Full text]
- Basic Science Reports
Anticoagulants (Thrombin Inhibitors) and Aspirin Synergize With P2Y12 Receptor Antagonism in Thrombosis
- Patrick André, Thomas LaRocca, Suzanne M. Delaney, Pei Hua Lin, Diana Vincent, Uma Sinha, Pamela B. Conley, and David R. Phillips
Circulation 2003;108:2697-2703; published online before print as doi:10.1161/01.CIR.0000093279.36628.12
[Abstract]
[Full text]
|
|
